ID   AN32B_RAT               Reviewed;         272 AA.
AC   Q9EST6;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-OCT-2024, entry version 130.
DE   RecName: Full=Acidic leucine-rich nuclear phosphoprotein 32 family member B;
DE   AltName: Full=Proliferation-related acidic leucine-rich protein PAL31;
GN   Name=Anp32b; Synonyms=Pal31;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar Imamichi; TISSUE=Brain;
RX   PubMed=10913355; DOI=10.1006/bbrc.2000.3133;
RA   Mutai H., Toyoshima Y., Sun W., Hattori N., Tanaka S., Shiota K.;
RT   "PAL31, a novel nuclear protein, expressed in the developing brain.";
RL   Biochem. Biophys. Res. Commun. 274:427-433(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11162633; DOI=10.1006/bbrc.2000.4244;
RA   Sun W., Hattori N., Mutai H., Toyoshima Y., Kimura H., Tanaka S.,
RA   Shiota K.;
RT   "PAL31, a nuclear protein required for progression to the S phase.";
RL   Biochem. Biophys. Res. Commun. 280:1048-1054(2001).
RN   [4]
RP   FUNCTION.
RX   PubMed=16499868; DOI=10.1016/j.bbrc.2006.02.026;
RA   Sun W., Kimura H., Hattori N., Tanaka S., Matsuyama S., Shiota K.;
RT   "Proliferation related acidic leucine-rich protein PAL31 functions as a
RT   caspase-3 inhibitor.";
RL   Biochem. Biophys. Res. Commun. 342:817-823(2006).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=15895553; DOI=10.1080/14734220410019020;
RA   Matilla A., Radrizzani M.;
RT   "The Anp32 family of proteins containing leucine-rich repeats.";
RL   Cerebellum 4:7-18(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; SER-171 AND THR-265, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Multifunctional protein that is involved in the regulation of
CC       many processes including cell proliferation, apoptosis, cell cycle
CC       progression or transcription. Regulates the proliferation of neuronal
CC       stem cells, differentiation of leukemic cells and progression from G1
CC       to S phase of the cell cycle (PubMed:11162633). As negative regulator
CC       of caspase-3-dependent apoptosis, may act as an antagonist of ANP32A in
CC       regulating tissue homeostasis (PubMed:16499868). Exhibits histone
CC       chaperone properties, able to recruit histones to certain promoters,
CC       thus regulating the transcription of specific genes. Also plays an
CC       essential role in the nucleocytoplasmic transport of specific mRNAs via
CC       the uncommon nuclear mRNA export receptor XPO1/CRM1 (By similarity).
CC       Participates in the regulation of adequate adaptive immune responses by
CC       acting on mRNA expression and cell proliferation (By similarity).
CC       {ECO:0000250|UniProtKB:Q92688, ECO:0000250|UniProtKB:Q9EST5,
CC       ECO:0000269|PubMed:11162633, ECO:0000269|PubMed:16499868}.
CC   -!- SUBUNIT: Interacts with histones H3 and H4. Interacts with KLF5; this
CC       interaction induces promoter region-specific histone incorporation and
CC       inhibition of histone acetylation by ANP32B.
CC       {ECO:0000250|UniProtKB:Q92688}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10913355,
CC       ECO:0000269|PubMed:11162633}. Note=Accumulates in the nuclei at the S
CC       phase.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain. Expressed in the
CC       entire embryonic brain, whereas in the adult brain its expression is
CC       restricted to the subventricular zone where there are neural progenitor
CC       cells. {ECO:0000269|PubMed:10913355}.
CC   -!- INDUCTION: Expressed specifically during the late G1 and S phases.
CC   -!- DOMAIN: Histone binding is mediated by the concave surface of the LRR
CC       region. {ECO:0000250}.
CC   -!- PTM: Some glutamate residues are glycylated by TTLL8. This modification
CC       occurs exclusively on glutamate residues and results in a glycine chain
CC       on the gamma-carboxyl group (By similarity). {ECO:0000250}.
CC   -!- PTM: Directly cleaved by caspase-3/CASP3.
CC       {ECO:0000250|UniProtKB:Q92688}.
CC   -!- MISCELLANEOUS: Suppression of the expression of this gene by RNAi
CC       induces apoptosis.
CC   -!- SIMILARITY: Belongs to the ANP32 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB025581; BAB12435.1; -; mRNA.
DR   EMBL; BC086508; AAH86508.1; -; mRNA.
DR   PIR; JC7357; JC7357.
DR   RefSeq; NP_571986.1; NM_131911.2.
DR   AlphaFoldDB; Q9EST6; -.
DR   SMR; Q9EST6; -.
DR   BioGRID; 250983; 2.
DR   IntAct; Q9EST6; 1.
DR   MINT; Q9EST6; -.
DR   STRING; 10116.ENSRNOP00000012478; -.
DR   iPTMnet; Q9EST6; -.
DR   PhosphoSitePlus; Q9EST6; -.
DR   SwissPalm; Q9EST6; -.
DR   jPOST; Q9EST6; -.
DR   PaxDb; 10116-ENSRNOP00000012478; -.
DR   Ensembl; ENSRNOT00000012478.6; ENSRNOP00000012478.5; ENSRNOG00000009266.7.
DR   Ensembl; ENSRNOT00055036165; ENSRNOP00055029378; ENSRNOG00055021171.
DR   Ensembl; ENSRNOT00060008091; ENSRNOP00060006061; ENSRNOG00060004865.
DR   Ensembl; ENSRNOT00065016934; ENSRNOP00065012969; ENSRNOG00065010456.
DR   GeneID; 170724; -.
DR   KEGG; rno:170724; -.
DR   UCSC; RGD:621285; rat.
DR   AGR; RGD:621285; -.
DR   CTD; 10541; -.
DR   RGD; 621285; Anp32b.
DR   eggNOG; KOG2739; Eukaryota.
DR   GeneTree; ENSGT00950000182907; -.
DR   InParanoid; Q9EST6; -.
DR   OrthoDB; 1386993at2759; -.
DR   PhylomeDB; Q9EST6; -.
DR   PRO; PR:Q9EST6; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0042393; F:histone binding; ISO:RGD.
DR   GO; GO:0070063; F:RNA polymerase binding; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:RGD.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0060021; P:roof of mouth development; ISO:RGD.
DR   GO; GO:0001944; P:vasculature development; ISO:RGD.
DR   GO; GO:0021591; P:ventricular system development; ISO:RGD.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR045081; AN32.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR003603; U2A'_phosphoprotein32A_C.
DR   PANTHER; PTHR11375; ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32; 1.
DR   PANTHER; PTHR11375:SF2; ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY MEMBER B; 1.
DR   Pfam; PF14580; LRR_9; 1.
DR   SMART; SM00446; LRRcap; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS51450; LRR; 3.
PE   1: Evidence at protein level;
KW   Chaperone; Leucine-rich repeat; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN           1..272
FT                   /note="Acidic leucine-rich nuclear phosphoprotein 32 family
FT                   member B"
FT                   /id="PRO_0000236253"
FT   REPEAT          16..40
FT                   /note="LRR 1"
FT   REPEAT          43..64
FT                   /note="LRR 2"
FT   REPEAT          65..84
FT                   /note="LRR 3"
FT   REPEAT          89..110
FT                   /note="LRR 4"
FT   DOMAIN          123..161
FT                   /note="LRRCT"
FT   REGION          149..272
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           260..263
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q92688"
FT   COMPBIAS        152..254
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        255..272
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         265
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   272 AA;  31061 MW;  556AC9B169E9D996 CRC64;
     MDMKRRIHLE LRNRTPAAVQ ELVLDNCKAN DGKIEGLTDE FVNLEFLSLI NVGLFSVSDL
     PKLPKLKKLE LSENRIFGGL DRLAEELPSL THLNLSGNNL KDISTLEPLK RLDCLKSLDL
     FGCEVTNRSD YRETVFRLLP QLSYLDGYDR EDQEAPDSDV EVDSVEEAPD SDGEVDGVDK
     EEEDEEGEDE EEEEDEDGEE EEDEDEEDED EDEDVEGEDD EDEVSGEEEE FGHDGEVDED
     EEDEDEDEDE EEEESGKGEK RKRETDDEGE DD
//
